Arrowhead Pharmaceuticals, Inc.

NORTHERN TRUST CORP ARWR

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/17/2026

Shares

1,346,257

Value ($000)

89,378

Weight

0.0%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/17/2026	89,378	0.0%	1,346,257	12/31/2025
2025 Q3	11/14/2025	45,237	0.0%	1,311,590	9/30/2025
2025 Q2	8/13/2025	20,099	0.0%	1,272,066	6/30/2025
2025 Q1	5/13/2025	15,426	0.0%	1,210,813	3/31/2025
2024 Q4	2/14/2025	27,907	0.0%	1,484,419	12/31/2024
2024 Q3	11/13/2024	25,816	0.0%	1,332,765	9/30/2024
2024 Q2	8/14/2024	34,377	0.0%	1,322,718	6/30/2024
2024 Q1	5/14/2024	37,199	0.0%	1,300,649	3/31/2024
2023 Q4	2/13/2024	37,626	0.0%	1,229,615	12/31/2023
2023 Q3	11/13/2023	34,034	0.0%	1,266,601	9/30/2023
2023 Q2	8/11/2023	46,297	0.0%	1,298,283	6/30/2023
2023 Q1	5/15/2023	33,528	0.0%	1,319,992	3/31/2023
2022 Q4	2/13/2023	52,071	0.0%	1,283,800	12/31/2022
2022 Q3	11/14/2022	42,273	0.0%	1,279,056	9/30/2022
2022 Q2	8/12/2022	45,637	0.0%	1,296,143	6/30/2022
2022 Q1	5/13/2022	63,715	0.0%	1,385,394	3/31/2022
2021 Q4	2/8/2022	94,288	0.0%	1,422,149	12/31/2021
2021 Q3	11/15/2021	90,145	0.0%	1,443,951	9/30/2021
2021 Q2	8/13/2021	123,488	0.0%	1,491,038	6/30/2021
2021 Q1	5/12/2021	102,521	0.0%	1,546,068	3/31/2021
2020 Q4	2/11/2021	119,578	0.0%	1,558,425	12/31/2020
2020 Q3	11/16/2020	68,695	0.0%	1,595,308	9/30/2020
2020 Q2	8/14/2020	72,765	0.0%	1,684,762	6/30/2020
2020 Q1	5/14/2020	46,584	0.0%	1,619,185	3/31/2020
2019 Q4	2/14/2020	98,489	0.0%	1,552,707	12/31/2019